Popular semaglutide-based drugs used for weight loss may reduce chronic and acute pain, which could make them a promising ...

Metsera has brought in over $500m in funding in just seven months as it looks to enter the competitive weight loss arena.

From constipation to muscle loss, the side effects of some weight loss and diabetes medications can be daunting to patients.

Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, ...

Novo Nordisk, which manufactures weight-loss drug Wegovy and diabetes medication Ozempic ... at a compounding pharmacy that ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.